Advanced search
Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 25, 2013 - Issue 11
Submit an article Journal homepage
250
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA

Gary SchneiderUnited BioSource Corporation, Lexington, MA, USACorrespondence[email protected]
,
Timothy JudayBristol-Myers Squibb, Plainsboro, NJ, USA
,
Charles Wentworth IIIUnited BioSource Corporation, Lexington, MA, USA
,
Stephan LanesUnited BioSource Corporation, Lexington, MA, USA
,
Tony HebdenBristol-Myers Squibb, Plainsboro, NJ, USA
&
Daniel SeekinsBristol-Myers Squibb, Plainsboro, NJ, USA
Pages 1470-1476 | Received 11 Oct 2012, Accepted 05 Feb 2013, Published online: 21 Mar 2013

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Amanda M. Farr, Stephen S. Johnston, Corey Ritchings, Matthew Brouillette & Lisa Rosenblatt. (2016) Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting. Journal of Medical Economics 19:4, pages 386-396.
Read now
John Bissler, Katherine Cappell, Hearns Charles, Xue Song, Zhimei Liu, Judith Prestifilippo & John Hulbert. (2015) Rates of interventional procedures in patients with tuberous sclerosis complex-related renal angiomyolipoma. Current Medical Research and Opinion 31:8, pages 1501-1507.
Read now

Articles from other publishers (9)

Deborah Goldstein, W. David Hardy, Anne Monroe, Qingjiang Hou, Rachel Hart & Arpi Terzian. (2020) Despite early Medicaid expansion, decreased durable virologic suppression among publicly insured people with HIV in Washington, DC: a retrospective analysis. BMC Public Health 20:1.
Crossref
AW Jabs, DA Jabs, ML Van Natta, FJ Palella & CL Meinert. (2018) Insurance status and mortality among patients with AIDS. HIV Medicine 19:1, pages 7-17.
Crossref
Rhodri Dierst-Davies, Amy Rock Wohl, Glenda Pinney, Christopher H. Johnson, Craig Vincent-Jones & Mario J. Pérez. (2015) Methods to Obtain a Representative Sample of Ryan White-Funded Patients for a Needs Assessment in Los Angeles County: Results from a Replicable Approach. Journal of the International Association of Providers of AIDS Care (JIAPAC) 16:4, pages 383-395.
Crossref
Christina Ludema, Stephen R. Cole, Joseph J. Eron, Andrew Edmonds, G. Mark Holmes, Kathryn Anastos, Jennifer Cocohoba, Mardge Cohen, Hannah L. F. Cooper, Elizabeth T. Golub, Seble Kassaye, Deborah Konkle-Parker, Lisa Metsch, Joel Milam, Tracey E. Wilson & Adaora A. Adimora. (2016) Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006–2009. JAIDS Journal of Acquired Immune Deficiency Syndromes 73:3, pages 307-312.
Crossref
David B. HannaUriel R. FelsenMindy S. GinsbergBarry S. ZingmanRobert S. BeilDonna C. FuttermanHoward D. StricklerKathryn Anastos. (2016) Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies. AIDS Research and Human Retroviruses 32:10-11, pages 955-963.
Crossref
Jeannette Y. Lee, Ishwori Dhakal, Corey Casper, Ariela Noy, Joel M. Palefsky, Missak Haigentz, Susan E. Krown, Richard F. Ambinder & Ronald T. Mitsuyasu. (2016) Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy. Journal of Cancer Epidemiology 2016, pages 1-9.
Crossref
Manjiri Pawaskar, Katherine R. Tuttle, Qian Li, Jennie H. Best & Pamela W. Anderson. (2014) Observational Study of Kidney Function and Albuminuria in Patients With Type 2 Diabetes Treated With Exenatide BID Versus Insulin Glargine. Annals of Pharmacotherapy 48:5, pages 571-576.
Crossref
Cynthia Gay, Ada Adimora, William Miller & Myron S. Cohen. (2014) Surveillance of HIV in the United States and England, Wales, and Northern Ireland. Sexually Transmitted Diseases 41:4, pages 266-267.
Crossref
Fred J. Hellinger. (2013) Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the US. PharmacoEconomics 31:12, pages 1091-1104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.